Retinoids — The Gold Standard Face Cream That Nothing Has Yet Replaced

Decades of use, an unmatched evidence base, and a breadth of biological effect that no newer topical ingredient has come close to replicating. Here is an honest clinical account of what retinoids actually do, how the different forms compare, and why the gentlest option is not always the wisest choice.

A five-decade head start

The story of retinoids in dermatology begins not with anti-ageing but with acne. Tretinoin (all-trans retinoic acid) was first approved for acne treatment in the 1960s. Its anti-ageing properties were identified almost by accident, as patients and clinicians observed that skin treated with tretinoin looked not just clearer but structurally improved, smoother, firmer, more evenly pigmented, with a quality of renewal that went well beyond what acne treatment alone could explain.

The subsequent decades of research into that observation have produced one of the most robust evidence bases in all of dermatology. No topical skincare ingredient has been studied as thoroughly, over as long a period, or with as consistently positive results as retinoic acid and its derivatives.

That head start matters clinically. When a patient asks whether a new topical ingredient might be as effective as their retinoid, the honest answer almost always begins with an acknowledgement that nothing has had the time, the research investment, or the clinical validation to make that comparison confidently. The newer ingredients may be promising. The retinoid evidence is established.

What is a retinoid?

The term "retinoid" refers to the entire family of vitamin A derivatives, both natural and synthetic, that share the ability to bind to retinoic acid receptors in the skin and influence gene expression. The family includes several distinct compounds that are encountered in clinical and cosmeceutical practice, and understanding their relationship to one another is essential for everything that follows.

At the top of the hierarchy sits tretinoin, all-trans retinoic acid, the fully active form that binds directly to nuclear receptors without any conversion.

One step removed is retinaldehyde (also called retinal), which requires a single enzymatic conversion to become retinoic acid.

Two steps removed is retinol — the form most commonly found in over-the-counter skincare — which must be converted first to retinaldehyde and then to retinoic acid before it can exert any biological effect.

Further still are the retinyl esters, retinyl palmitate & retinyl acetate, which require an additional hydrolysis step before entering the conversion pathway.

Beyond these naturally occurring forms sit the synthetic retinoids: adapalene, tazarotene, and the newer hydroxypinacolone retinoate (HPR), each designed to interact with specific receptor subtypes or bypass the conversion pathway in different ways.

What retinoids actually do

The breadth of retinoid effect at the cellular and molecular level is, genuinely, remarkable. Topical tretinoin's mechanisms include keratolytic activity, regulation of proliferation and differentiation of epidermal cells, activation of fibroblasts, induction of collagen synthesis and collagen recycling, prevention of collagen loss, reduction in matrix metalloproteinases MMP-1 and MMP-8, and a decrease in epidermal melanin through inhibition of tyrosine kinase.

Retinoids accelerate the turnover of the epidermal surface, producing a progressive improvement in skin texture and tone.

They stimulate dermal fibroblasts to produce new collagen while simultaneously inhibiting the enzymes responsible for collagen degradation — a dual action that is particularly valuable in ageing skin where both processes are dysregulated.

They normalise the disordered Pigmentation (visit the up coming site) that accumulates with sun exposure.

They improve the organisation of the stratum corneum.